フルテキストファイル
著者
Nishii-Ito, Shizuka Department of Hematology, Tottori University Hospital / Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
Izumi, Hiroki Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
Touge, Hirokazu Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
Takeda, Kenichi Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
Hosoda, Yuzuru Department of Hematology, Tottori University Hospital / Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University 研究者総覧
Yamasaki, Akira Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Kuwamoto, Satoshi Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Shimizu, Eiji Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University KAKEN
Motokura, Toru Department of Hematology, Tottori University Hospital / Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
キーワード
intravascular large B-cell lymphoma
rituximab
ground-glass opacities
抄録
A 73-year-old man with a history of lethargy, fever and dyspnea was admitted to Tottori University Hospital. A computed tomography (CT) scan revealed splenomegaly and diffusely spreading ground‑glass opacities (GGOs) in both lungs. A video‑assisted thoracoscopic surgery (VATS)‑guided lung biopsy revealed intravascular proliferation of large atypical lymphoid cells in the arteries, veins and alveolar walls. The patient was diagnosed with intravascular large B‑cell lymphoma (IVLBCL); he received 6 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R‑CHOP) immunochemotherapy and has remained in complete remission for >1 year. Although IVLBCL is a rare disease, it should be considered in the differential diagnosis of pulmonary diffuse lesions that present with GGOs on CT scans.
出版者
Spandidos Publications
資料タイプ
学術雑誌論文
外部リンク
ISSN
20499450
EISSN
20499469
掲載誌名
MOLECULAR AND CLINICAL ONCOLOGY
最新掲載誌名
MOLECULAR AND CLINICAL ONCOLOGY
5
6
開始ページ
689
終了ページ
692
発行日
2016-12
出版者DOI
著者版フラグ
出版社版
著作権表記
© Nishii‑Ito et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
掲載情報
Nishii-Ito Shizuka, Izumi Hiroki, Touge Hirokazu, et al. Pulmonary intravascular large B-cell lymphoma successfully treated with rituximab, cyclophosphamide, vincristine, doxorubicin and prednisolone immunochemotherapy: Report of a patient surviving for over 1 year. MOLECULAR AND CLINICAL ONCOLOGY. 2016. 5(6). 689-692. doi:10.3892/mco.2016.1063
部局名
医学部・医学系研究科・医学部附属病院
言語
英語
Web of Science Key ut
WOS:000453169800004